Skip to main content
Premium Trial:

Request an Annual Quote

Perlegen Hires First CFO; Structural Genomics Taps Drug-Discovery Veep; Agencourt Fleshes Out Science Board

NEW YORK, July 3 - Perlegen Sciences has chosen Matthew Furst as its first chief financial officer, the company said last week.

 

Furst joins Perlegen from ALZA Corporation, where he was senior vice president and chief financial officer until the firm's acquisition by Johnson & Johnson.

 


 

Lexicon Genetics last week named Lorraine Marchand vice president of corporate communications.

 

Marchand was formerly executive director of the pharmaceutical research institute of Bristol-Myers Squibb.

 


 

Structural Genomics has hired Ian McDonald to be its new vice president of drug discovery, the firm announced one week ago.

 

McDonald used to be vice president of drug discovery for Structural Bioinformatics after a stint as vice president of chemistry with Merck Research Laboratories.

 


 

Indian bioinformatics company Strand Genomics has tapped Charles Delisi to join its scientific advisory board.

 

Delisi heads the Biomolecular Systems Laboratory at the Center for Advanced Genomics Technology.

 


 

Agencourt Bioscience said Eugene Della Vecchia would join its board of directors.

 

Della Vecchia is president of Harbor View Associates, a technology-based marketing and sales consulting company. Previously, he has been vice president of worldwide sales for Packard Bioscience.

 


 

Promoted? Changing jobs? GenomeWeb wants to know. E-mail Kathleen McGowan at [email protected] to appear in PEOPLE, a roundup of personnel comings and goings in genomics that appears every Wednesday.

The Scan

Removal Inquiry

The Wall Street Journal reports that US lawmakers are seeking additional information about the request to remove SARS-CoV-2 sequence data from a database run by the National Institutes of Health.

Likely to End in Spring

Free lateral flow testing for SARS-CoV-2 may end in the UK by next spring, the head of Innova Medical Group says, according to the Financial Times.

Searching for More Codes

NPR reports that the US Department of Justice has accused an insurance and a data mining company of fraud.

Genome Biology Papers on GWAS Fine-Mapping Method, COVID-19 Susceptibility, Rheumatoid Arthritis

In Genome Biology this week: integrative fine-mapping approach, analysis of locus linked to COVID-19 susceptibility and severity, and more.